Partner With Us NRI

Metropolis Healthcare Ltd share Price

Company details

6M Return 21.97%
1Y Return -4.72%
Mkt Cap.(Cr) 7,504.97
Volume 77,454
Div Yield 0.55%
OI Chg %
Volume 77,454

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Metropolis Healthcare announced Q1FY24 results:

  • Core business revenue growth stood at Rs 271 crore, up 12% YoY with 9% volume growth & 3% RPT growth
  • Core business patients stood at 2.7 million with a growth of 9% YoY
  • Total B2C revenue in grew by 13% for Q1FY24 YoY with volume growth of 9%
  • EBIDTA before network expansion stood at 25.3%
  • Premium wellness segments revenue grew by 27% & volumes grew by 38% indicating strong brand equity & consumer trust on Metropolis.
  • Contribution of premium wellness stood at 15%
  • B2C revenue growth in Mumbai stood at 15% on account of our strong brand presence & dense network

“In Q1FY24, the core business revenues grew by 12% YoY, reflecting a consistent trend of double-digit growth over the past five quarters for its core revenues. Total Revenues for Q1FY24 were down by 1% primarily on account of a large B2G contract insourced by the Government & a high base of Covid & Allied tests. The company remains optimistic about scaling up revenue in the upcoming quarters, indicating positive operating leverage play.

B2C revenue grew by 13% YoY with Mumbai revenues for B2C growing by over 15%. Metropolis has witnessed growth across the test mix in B2C markets with Specialised and Wellness segments growing by 15% & 19% respectively on a YoY basis.

Going forward, the company focuses on network expansion, increasing doctor connections, growing specialised & wellness segments, and upgrading IT infrastructure to enhance the consumer experience. We firmly believe that Metropolis is in an advantageous position to achieve a higher market share across various geographies and surpass industry growth", said Ameera Shah, Promoter and Managing Director, Metropolis Healthcare.



Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Metropolis Healthcare Ltd Stocks COMPARISION


Equity Capital: 988.23 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 11,335.64 -17,804.06
LAST 3M 47,117.37 -471.49
LAST 6M 52,173.28 142,982.97
LAST 12M 128,656.49 169,390.95
Metropolis Healthcare Limited - Trading Window

Sep 29, 2023 l NSE Announcement

Metropolis Healthcare Limited - Copy of Newspaper Publication

Sep 28, 2023 l NSE Announcement

Date Action Type Ratio
Feb 23, 2023 Dividend 400
Feb 21, 2022 Dividend 400
Feb 17, 2021 Dividend 400

Metropolis Healthcare Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
Registered Address

250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030

Tel : 91-22-62582810
Email : secretarial:metropolisindia.com
Website : http://www.metropolisindia.com

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 542650
Book Closure Date (Month) :
BSE Group : A
ISIN : INE112L01020

FAQ’s on Metropolis Healthcare Ltd Shares

You can buy Metropolis Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Metropolis Healthcare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Oct 03, 2023 10:24 AM the closing price of Metropolis Healthcare Ltd was ₹ 1,465.50.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Oct 03, 2023 10:24 AM, the market cap of Metropolis Healthcare Ltd stood at ₹ 7,504.97.

The latest PE ratio of Metropolis Healthcare Ltd as of Oct 03, 2023 10:24 AM is 54.04

The latest PB ratio of Metropolis Healthcare Ltd as of Oct 03, 2023 10:24 AM is 0.13

The 52-week high of Metropolis Healthcare Ltd is ₹ 1,791.20 while the 52-week low is ₹ 1,171.35

Download Our App

market app
market app